Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases.
分子式
C6H17NO7P2
分子量
277.15
CAS号
79778-41-9
中文名称
奈立膦酸
运输条件
Room temperature in continental US; may vary elsewhere.